Sponsoring the Targeted Cancer Therapy World Congress 2010 is a time and cost-effective opportunity to develop existing and new business.
Sponsorship packages offer your company thought-leadership positioning, branding, and the opportunity to set up face-to-face meetings with hundreds of decision makers from your target market in just 3 working days.
"Dr. Lars Knoch was born in Luebeck, north Germany and started his biological career in south Germany in the mid 90´s at the well known Eberhardt-Karls University of Tuebingen. After finishing his Diploma thesis about the molecular function of HOX genes, he started his PhD at the Max-Planck Institute for Developmental Biology in the Department of Prof. Dr. Ralf Sommer working in the field of molecular evolutionary biology. Scientific topics of his PhD thesis were the formation of the HOX-Cluster and the function of the EGF-Pathway in a closely related species of C. elegans called Pristionchus pacificus. He finished his thesis in the beginning of the year 2007 and since then he is working for Sigma-Aldrich. First working as a Sales Specialist in the life science section of SigmaAldrich.
Since this year he is responsible as the technical expert for the new and innovative Technology of ZincFinger Nucleases in the region of Europe, Middle East and South-Africa (EMEA). As the Scientific Consultant for this highly advanced technology he is supporting customers in their daily needs and questions regarding ongoing and future projects."
Appearing:
DAY 2 WEDNESDAY 22 SEPTEMBER – IMPROVING PRE-CLINICAL & EARLY DEVELOPMENT
5.10pm
Knockout rat models for cancer research and drug discovery
Zinc Finger Nuclease technology is a powerful tool for the targeted manipulation of genomes and has been utilised successfully in vitro for a broad array of applications. This technology has now been applied to an in vivo setting.
The first creation of a number of ready-to-use rat models including a p53 knockout rat and a Mdr1a knockout rat.
Short overview of future trends in this technology and other ready-to-use rat models in the future.
Sponsoring Targeted Cancer
Therapy World Congress 2010
is a time and cost-effective opportunity to develop
existing and new business.
Sponsorship packages offer your company thought-leadership positioning, branding, and the opportunity to set up face-to-face meetings with hundreds of decision makers from your target market in just 3 working days.
